Eczema Area and Severity Index (EASI)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۶
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۶
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۶
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۶
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Clear0–0
- Almost Clear0.1–1
- Mild1.1–7
- Moderate7.1–21
The Eczema Area and Severity Index (EASI) calculates quantifying total body surface area involvement and staging cutaneous or blistering disease severity. Key inputs include age category. Scores guide calculating resuscitation fluid protocols, administering topical or systemic corticosteroids, and wound care. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Stratifies eczema severity by assessing area involvement and severity signs across four body regions (head/neck, upper extremities, trunk, lower extremities) with validated clinical scoring.
Clinical Indication
The Eczema Area and Severity Index (EASI) is indicated for bedside clinical practice to support Stratifies eczema severity by assessing area involvement and severity signs across four body regions (head/neck, upper extremities, trunk, lower extremities) with validated clinical scoring.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute thermal burns, extensive bullous eruptions, severe psoriasis, or severe cutaneous adverse reactions. Clinical application is indicated across Dermatology clinics, burn centers, and emergency dermatology triage.
Limitations & Contraindications
Rule of Nines overestimates burn surface area in pediatric anatomy; Lund-Browder charts must be utilized.
Clinical Pearls & Action Plan
Full-body cutaneous examination including all mucous membranes and scalp is necessary to detect early epidermal detachment. Guideline pearl: Recommended for clinical trials and research as primary efficacy endpoint..
EASI = 0.1 × (erythema + edema + excoriation + lichenification) × area_score × head_neck_multiplier + 0.2 × (erythema + edema + excoriation + lichenification) × area_score × upper_extremities_multiplier + 0.3 × (erythema + edema + excoriation + lichenification) × area_score × trunk_multiplier + 0.4 × (erythema + edema + excoriation + lichenification) × area_score × lower_extremities_multiplier. Regional multipliers: Head/neck = 0.1 (adults), 0.2 (children 0-7); Upper extremities = 0.2; Trunk = 0.3; Lower extremities = 0.4.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_category | string | Yes | Patient age category for regional multiplier calculation |
| head_neck_area | integer | Yes | Head and neck area involvement score (0=0%, 1=1-9%, 2=10-29%, 3=30-49%, 4=50-69%, 5=70-89%, 6=90-100%) |
| head_neck_erythema | integer | Yes | Head and neck erythema severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| head_neck_edema | integer | Yes | Head and neck edema/papulation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| head_neck_excoriation | integer | Yes | Head and neck excoriation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| head_neck_lichenification | integer | Yes | Head and neck lichenification severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| upper_extremities_area | integer | Yes | Upper extremities area involvement score (0=0%, 1=1-9%, 2=10-29%, 3=30-49%, 4=50-69%, 5=70-89%, 6=90-100%) |
| upper_extremities_erythema | integer | Yes | Upper extremities erythema severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| upper_extremities_edema | integer | Yes | Upper extremities edema/papulation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| upper_extremities_excoriation | integer | Yes | Upper extremities excoriation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| upper_extremities_lichenification | integer | Yes | Upper extremities lichenification severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| trunk_area | integer | Yes | Trunk area involvement score (0=0%, 1=1-9%, 2=10-29%, 3=30-49%, 4=50-69%, 5=70-89%, 6=90-100%) |
| trunk_erythema | integer | Yes | Trunk erythema severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| trunk_edema | integer | Yes | Trunk edema/papulation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| trunk_excoriation | integer | Yes | Trunk excoriation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| trunk_lichenification | integer | Yes | Trunk lichenification severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| lower_extremities_area | integer | Yes | Lower extremities area involvement score (0=0%, 1=1-9%, 2=10-29%, 3=30-49%, 4=50-69%, 5=70-89%, 6=90-100%) |
| lower_extremities_erythema | integer | Yes | Lower extremities erythema severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| lower_extremities_edema | integer | Yes | Lower extremities edema/papulation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| lower_extremities_excoriation | integer | Yes | Lower extremities excoriation severity (0=absent, 1=mild, 2=moderate, 3=severe) |
| lower_extremities_lichenification | integer | Yes | Lower extremities lichenification severity (0=absent, 1=mild, 2=moderate, 3=severe) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Clear | No eczema |
| 0.1–1 | Almost Clear | Almost clear eczema |
| 1.1–7 | Mild | Mild eczema |
| 7.1–21 | Moderate | Moderate eczema |
| 21.1–50 | Severe | Severe eczema |
| 50.1–72 | Very Severe | Very severe eczema |
Evidence-Based References (EBM)
- Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-8. doi: 10.1034/j.1600-0625.2001.100102.x.DOI: 10.1034/j.1600-0625.2001.100102.x
- Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337-47. doi: 10.1016/j.jaci.2013.07.008.DOI: 10.1016/j.jaci.2013.07.008
- Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73(6):1284-1293. doi: 10.1111/all.13401.DOI: 10.1111/all.13401
- Silverberg JI, Paller AS, Fishbein AB, Kaplan DH, Simpson EL. Eczema prevalence, severity and impact in the United States. Dermatitis. 2019;30(1):66-72. doi: 10.1097/DER.0000000000000408.DOI: 10.1097/DER.0000000000000408